Japan Endovascular Treatment Conference 2025 (JET2025)

Japan Endovascular Treatment Conference 2025 (JET2025)

Call for Abstracts

Pre Site Open

LBCT
JETOPEN-the world

JETOPEN-the world

Guideline

JET25 calls for cases and abstracts. Please read all the information below and submit your abstracts from the link below.
Multiple applications are allowed. If you submit several cases/abstracts, please submit one by one.

The most outstanding case/abstract will be given an award during "Closing Ceremony" which will be held on April 27th (Sunday). The presenter must give the same presentation for this session.

We welcome the submission of the theme not only from doctors and medical staff but also from people interested in peripheral vascular treatment.

Categories

1) LEAD
2) Aortic
3) Venous
4) AV access

Submission Period

Case and Abstract submission is now closed.
The meeting organizers wish to thank everyone for your submissions.

Qualification Requirements

Must be able to attend JET25 on April 25th -27th, 2025 if your case(s)/abstract(s) is(are) accepted for presentation.

Application Method

Submit abstracts through website. Abstracts must be no more than 200 words exclude name and title.
You may include up to 1 figure or image with your abstract - the figure and image must have a title.

*
You may confirm / modify your abstracts up to the deadline using your ID number and password.

Submission Confirmation

After completing all the submission process, you will receive a confirmation E-mail. If you do not receive a confirmation E-mail, please contact the secretariat. You may have entered a wrong E- mail address or may have failed to complete your submission.

Presentation Style

Presentation Style: 1.Oral 2. Digital Poster (no presentations)
Language: English (Both Oral and Slide)
Presentation Time: 6 minutes presentation, 4 minutes Q&A.
PowerPoint Slide: Maximum of 20 slides. Must be used JET25 Slide Master.

Please note...

  • All abstracts will be peer reviewed by JET25 program committee.
  • Results will be informed via E-mail around the end of January.
  • Registration fee will be waived for presenters. However, the Congress will not be able to absorb the expenses related to travel and accommodation.
  • Presentation schedule will be arranged by the Congress.

If you have any questions, please contact the secretariat as shown below.

JET25 Secretariat
c/o Congrès Inc.
E-mail: jet2025[A]congre[D]co[D]jp( Please change [A] to @ and [D] to . )

LBCT

Submission Period

LBCT(late-breaking clinical trial)submission is now closed.
The meeting organizers wish to thank everyone for your submissions.

Qualification Requirements

Must be able to attend JET25 on April 25th -26th, 2025 if your abstract is accepted for LBCT (late-breaking clinical trial) and the latest data session.

Application Method

  • Download and create a document template (Microsoft Word).
  • Please email the abstract to the JET Secretariat at secretariat@j-et.jp.
  • The subject line of the e-mail should be “JET25 LBCT Submission”

Submission Confirmation

A confirmation email will be sent within one day after the email is sent. If you do not receive the confirmation email, please contact the office. The email address may be wrong or the email could not be sent.

Presentation Style

Presentation Style: Oral
Language: English (Both Oral and Slide)
Presentation Time: 6 minutes presentation, 3 minutes Q&A.

Please note...

  • All abstracts will be peer reviewed by JET25 program committee.
  • Results will be informed via E-mail around the end of January.
  • Abstracts not accepted by the LBCT will be considered for presentation at the Latest Data (Plenary) and other programs during JET25.
  • Registration fee will be waived for presenters. However, the Congress will not be able to absorb the expenses related to travel and accommodation.

If you have any questions, please contact the secretariat as shown below.

JET25 Secretariat
c/o Congrès Inc.
E-mail: jet2025[A]congre[D]co[D]jp( Please change [A] to @ and [D] to . )

Back to Top